NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

499.65 +10.41 (+2.13%)
As of 3:23 PM EDT. Market Open.
Loading Chart for IDXX
DELL
  • Previous Close 489.24
  • Open 484.03
  • Bid 499.44 x 100
  • Ask 500.21 x 100
  • Day's Range 484.03 - 500.34
  • 52 Week Range 372.50 - 583.39
  • Volume 325,844
  • Avg. Volume 419,345
  • Market Cap (intraday) 41.498B
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) 49.57
  • EPS (TTM) 10.08
  • Earnings Date May 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 604.62

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

www.idexx.com

11,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IDXX

Performance Overview: IDXX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IDXX
9.98%
S&P 500
7.15%

1-Year Return

IDXX
3.40%
S&P 500
25.52%

3-Year Return

IDXX
10.63%
S&P 500
22.26%

5-Year Return

IDXX
119.46%
S&P 500
74.66%

Compare To: IDXX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IDXX

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    40.63B

  • Enterprise Value

    41.25B

  • Trailing P/E

    48.63

  • Forward P/E

    44.84

  • PEG Ratio (5yr expected)

    4.67

  • Price/Sales (ttm)

    11.22

  • Price/Book (mrq)

    27.37

  • Enterprise Value/Revenue

    11.27

  • Enterprise Value/EBITDA

    33.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.08%

  • Return on Assets (ttm)

    22.83%

  • Return on Equity (ttm)

    80.74%

  • Revenue (ttm)

    3.66B

  • Net Income Avi to Common (ttm)

    845.04M

  • Diluted EPS (ttm)

    10.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    453.93M

  • Total Debt/Equity (mrq)

    71.90%

  • Levered Free Cash Flow (ttm)

    693.69M

Research Analysis: IDXX

Analyst Price Targets

460.00 Low
604.62 Average
499.65 Current
675.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: IDXX

Fair Value

499.65 Current
 

Dividend Score

0 Low
IDXX
Sector Avg.
100 High
 

Hiring Score

0 Low
IDXX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
IDXX
Sector Avg.
100 High
 

Research Reports: IDXX

  • IDXX: Raising target price to $518.00

    IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $518.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • IDXX: Lowering target price to $514.00

    IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $514.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • IDXX: Lowering target price to $546.00

    IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $546.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • IDXX: Lowering target price to $548.00

    IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $548.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch